BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Patrussi L, Capitani N, Baldari CT. Abnormalities in chemokine receptor recycling in chronic lymphocytic leukemia. Cell Mol Life Sci 2019;76:3249-61. [PMID: 30830241 DOI: 10.1007/s00018-019-03058-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Tatangelo V, Boncompagni G, Capitani N, Lopresti L, Manganaro N, Frezzato F, Visentin A, Trentin L, Baldari CT, Patrussi L. p66Shc Deficiency in Chronic Lymphocytic Leukemia Promotes Chemokine Receptor Expression Through the ROS-Dependent Inhibition of NF-κB. Front Oncol 2022;12:877495. [PMID: 35847884 DOI: 10.3389/fonc.2022.877495] [Reference Citation Analysis]
2 Patrussi L, Capitani N, Baldari CT. Interleukin (IL)-9 Supports the Tumor-Promoting Environment of Chronic Lymphocytic Leukemia. Cancers (Basel) 2021;13:6301. [PMID: 34944921 DOI: 10.3390/cancers13246301] [Reference Citation Analysis]
3 Vanni F, Lopresti L, Zurli V, Kabanova A, Cattaneo F, Sicuranza A, Gozzetti A, Gemma S, Zisterer DM, Bocchia M, Campiani G, Baldari CT, Butini S, Ulivieri C. A novel class of oxazepine-based anti-cancer agents induces cell death in primary human CLL cells and efficiently reduces tumor growth in Eμ-TCL1 mice through the JNK/STAT4/p66Shc axis. Pharmacol Res 2021;174:105965. [PMID: 34732370 DOI: 10.1016/j.phrs.2021.105965] [Reference Citation Analysis]
4 Patrussi L, Capitani N, Baldari CT. P66Shc: A Pleiotropic Regulator of B Cell Trafficking and a Gatekeeper in Chronic Lymphocytic Leukemia. Cancers (Basel) 2020;12:E1006. [PMID: 32325830 DOI: 10.3390/cancers12041006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
5 Finetti F, Capitani N, Manganaro N, Tatangelo V, Libonati F, Panattoni G, Calaresu I, Ballerini L, Baldari CT, Patrussi L. Optimization of Organotypic Cultures of Mouse Spleen for Staining and Functional Assays. Front Immunol 2020;11:471. [PMID: 32265925 DOI: 10.3389/fimmu.2020.00471] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
6 Márquez E, Mora JR, Flores-Morales V, Insuasty D, Calle L. Modeling the Antileukemia Activity of Ellipticine-Related Compounds: QSAR and Molecular Docking Study. Molecules 2019;25:E24. [PMID: 31861689 DOI: 10.3390/molecules25010024] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]